Efficacy of ruxolitinib in myeloid neoplasms with PCM1-JAK2 fusion gene

Keywords

RuxolitinibHematologyFusion geneMedicineInternal medicineMyeloidMyeloproliferative neoplasmOncologyGeneCancer researchMyelofibrosisBiologyGeneticsBone marrow

Affiliated Institutions

Related Publications

An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms

Tariq I. Mughal , Nicholas C.P. Cross , E. Padron +15 more

In the 2008 WHO classification, chronic myeloid malignancies that share both myelodysplastic and myeloproliferative features define the myelodysplastic/myeloproliferative group,...

2015 Haematologica 98 citations

The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features

Attilio Orazi , Ulrich Germing

2008 Leukemia 184 citations

SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations

Manja Meggendorfer , Ulrike Bacher , Tamara Alpermann +5 more

2013 Leukemia 186 citations

An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms

Ayalew Tefferi , J. Thiele , Alessandro M. Vannucchi +1 more

2014 Leukemia 215 citations

Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis

Tiziano Barbui , J. Thiele , Alessandro M. Vannucchi +1 more

2015 Blood Cancer Journal 119 citations

Publication Info

Year: 2015
Type: letter
Volume: 94
Issue: 11
Pages: 1927-1928
Citations: 59
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Efficacy of ruxolitinib in myeloid neoplasms with PCM1-JAK2 fusion gene

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

OpenAlex

Cite This

APA Style

                            
                                
                                    Elisa Rumi, 
                                
                                    Jelena D. Milosevic Feenstra, 
                                
                                    Dominik Selleslag
                                
                                et al.
                            
                            (2015). 
                            Efficacy of ruxolitinib in myeloid neoplasms with PCM1-JAK2 fusion gene. 
                            Annals of Hematology
                            , 94
                            (11)
                            , 1927-1928.
                            https://doi.org/10.1007/s00277-015-2451-7
                        

Identifiers

DOI: 10.1007/s00277-015-2451-7